Date: 2025/05/09 - 22:00
Attorneys general in 19 states and Washington, D.C., filed a lawsuit challenging the Trump administration's plans to significantly reduce staffing at the Department of Health and Human Services (HHS), which could disrupt public health services, such as safeguarding food and medication supplies.
Date: 2025/05/07 - 22:00
Republican leaders are considering drastic cuts to Medicaid funding. The cuts could have a significant impact on low-income households, older adults, children, and people with mental health disorders. Reduced federal funding could also affect access to reproductive health services.
Date: 2025/05/05 - 23:00
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.
Date: 2025/05/02 - 20:32
A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain cancers. People with the dMMR gene mutation, which most often presents in colorectal cancer, are the best candidates for this treatment.
Date: 2025/04/29 - 23:00
"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss. Experts say wrinkles and sagging skin can result from rapid weight loss due to loss of fat and muscle mass in certain areas of the body.
Date: 2025/04/26 - 00:00
The FDA issued a warning about adverse effects related to a popular hair loss product available through telehealth platforms like Hims & Hers and Ro. Men have reported side effects of topical finasteride, including depression, dizziness, and low libido.
Date: 2025/04/25 - 23:00
The FDA issued a warning about adverse effects related to a popular hair loss product available through telehealth platforms like Hims & Hers and Ro. Men have reported side effects of topical finasteride, including depression, dizziness, and low libido.
Date: 2025/04/18 - 20:00
A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin had fewer complications and deaths. The authors say that early combination therapy should become the standard of care.